Clinical Trials Sponsored by Groupe Fontalvie

Total 7989 results

Groupe SEBBIN

Recruiting

SEBBIN INTEGRITY Round Implants

Complication | Prosthesis Durability

France
Groupe SEBBIN

Active, not recruiting

Multicenter Post-marketing Survey of SEBBIN Group Silicone Gel-filled Breast Implants (IM02)

Breast Implant; Complications
Groupe Hospitalier Diaconesses Croix Saint-Simon
GERCOR - Multidisciplinary Oncology Cooperative Group

Recruiting

Two Therapeutic Strategies in First-line in Patients With Epithelial Advanced Ovarian Cancer (CHIMOVIP)

Ovarian Cancer, Epithelial

France
Groupe SEBBIN

Recruiting

SEBBIN Silicone Gel-filled Testicular Implants

Complication | Prosthesis Durability

Belgium, France
Groupe SEBBIN

Recruiting

SEBBIN Round, Anatomical and Biconvex Gluteal Implants

Complication | Prosthesis Durability

Netherlands
Groupe Oncologie Radiotherapie Tete et Cou
Tumor Study Group Head and Neck

Completed

Radiotherapy With Cisplatin Versus Radiotherapy With Cetuximab After Induction Chemotherapy for Larynx Preservation

Larynx Cancer | Hypopharynx Cancer

France
Bistro Study Group
Barts & The London NHS Trust; Groupe Hospitalier Pitie-Salpetriere

Completed

Biomarkers In Seizure To Predict Recurrence and Severe Outcomes (BISTRO)

Seizures | Copeptin | S-100b Protein

France, United Kingdom
Italian Sarcoma Group
French Sarcoma Group; Grupo Espanol de Investigacion en Sarcomas

Active, not recruiting

Localized High-Risk Soft Tissue Sarcomas Of The Extremities And Trunk Wall In Adults: An Integrating Approach Comprising Standard Vs Histotype-Tailored Neoadjuvant Chemotherapy

Localized High-risk Soft Tissue Sarcomas of the Extremities and Trunk Wall in Adults

Spain, Italy
AGO Study Group
European Network of Gynaecological Oncological Trial Groups (ENGOT)

Recruiting

Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cancer

Germany
Groupe Concepteur Touch

Active, not recruiting

Study of the Touch® Trapezo-metacarpal Prosthesis

Thumb Osteoarthritis | Complications Due to Internal Joint Prosthesis

France
Ascopharm Groupe Novasco

Completed

Open, Multicentric Trial Evaluating the Efficacy and the Clinical Tolerance of PA0903 as Root Canal Sealer (PA0903)

Root Canal Obturation

France, United Kingdom
Grupo Español de Rehabilitación Multimodal
GRACE Group; REDGERM

Unknown

Postopoperarive Outcomes After Colorectal Surgery in Europe (euroPOWER) (EuroPOWER)

Postoperative Complications | Colorectal Surgery | Perioperative Care

Spain
Groupe Kolmi Hopen

Completed

Evaluation of the Tolerance of Three Masks Under Dermatological Control.

Healthy Population

France
Seagen Inc.
Gynecologic Oncology Group; European Network of Gynaecological Oncological... and other collaborators

Completed

A Trial of Tisotumab Vedotin in Cervical Cancer

Cervical Cancer

Belgium, Spain, United States, Denmark, Italy, Germany, Czechia, Sweden
AstraZeneca
Gynecologic Oncology Group Foundation; European Network for Gynaecological...

Recruiting

Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical) (eVOLVECervical)

Locally Advanced Cervical Cancer

Spain, Denmark, Korea, Republic of, Italy, Japan, Peru, China, Brazil, Taiwan, United States, Canada, Turkey, India, Poland, Mexico, Puerto Rico, Norway
Groupe Mulliez-Flory
EVAMED

Recruiting

Evaluation of Safe Use of SECURIDRAP® SELFIA® (SECURIDRAP)

Cognitive Impairment | Behavior Disorders | Disorientation

France
Groupe Hospitalier Pitie-Salpetriere

Recruiting

JOint Use of Database to Identify Risk Factors of CARDio-vascular Toxicity Induced by Immune Checkpoint Inhibitors (JOCARDITE)

Heart Diseases | Cardiovascular Diseases | Vasculitis | Myocarditis | Cardiomyopathies | Pericarditis

France
Groupe Hospitalier du Havre

Not yet recruiting

Transcutaneous Electrical Nerve Stimulation During Exercise in Patients With COPD (proTENS)

Physical Activity | Rehabilitation | COPD | TEN

France
Groupe Francophone des Myelodysplasies

Recruiting

A Trial Testing Early vs Late Onset of EPO Alfa Treatment in Lower Risk MDS (EPO-PRETAR)

Myelodysplastic Syndromes

France
Groupe Francophone des Myelodysplasies

Active, not recruiting

IDH2 (AG 221) Inhibitor in Patients With IDH2 Mutated Myelodysplastic Syndrome

Myelodysplastic Syndromes | Leukemia Acute Myeloid

France
Groupe Hospitalier Pitie-Salpetriere

Completed

Lung Ultrasonography After Major Cardiac Surgery (ECHOVAP)

Pneumonia | Cardiopulmonary Bypass | Cardio/Pulm: Respiratory Failure
Groupe Hospitalier Pitie-Salpetriere

Completed

a Vigibase Pharmacovigilance Study of ENzalutamide Drug-induced neurotoxicitY (VENDY)

Epilepsy | Prostate Cancer | Neuropathy | Encephalopathy

France
Groupe Hospitalier Pitie-Salpetriere

Completed

Monitoring the Hyperammonaemia:TOXicity of Drugs (AmmoTOX) (AmmoTOX)

Metabolic Disease | Adverse Drug Event | Hyperammonemia | Drug Toxicity

France
Groupe Hospitalier Pitie-Salpetriere

Completed

Monitoring the HePAtological TOXicity of Drugs (HePATOX) (HePATOX)

Liver Diseases | Liver Failure | Liver Dysfunction | Hepatotoxicity

France
Groupe Hospitalier Pitie-Salpetriere

Completed

Joint Use of Electrocardiogram and Transthoracic Echocardiography With Other Clinico-biological Parameters in an Observational Study to Monitor Cardio-vascular Events and Predict Outcomes in Patients Diagnosed With COVID-19 (JOCOVID)

COVID-19 | Myocardial Injury | Myocarditis

France
Groupe Hospitalier du Havre

Completed

Slow Expiratory Technique to Improve Alimentation in Children With Bronchiolitis (BRONCHIOL-EAT)

Acute Viral Bronchiolitis

France
Groupe Hospitalier du Havre

Completed

Transcutaneous Diaphragm Electrical Stimulation in Critically Ill Patients (TESLA)

Critical Illness | Intensive Care Unit | Mechanical Ventilation

France
Groupe Hospitalier du Havre

Completed

Effects of Menthol on Dyspnoea in COPD Patients (MEDiC)

Lung Diseases | Copd | Dyspnea

France
Groupe Hospitalier Pitie-Salpetriere

Completed

Modeling of Amiodarone Effect on Heart Rate Control in Critically Ill Patients With Atrial Tachyarrhythmias (AMIRA)

Atrial Fibrillation | Atrial Tachycardia
Groupe Hospitalier du Havre

Completed

Energy Conservation Technique in COPD Patients (UpstAIR)

Chronic Obstructive Pulmonary Disease

France
Groupe Francophone des Myelodysplasies

Completed

Idarubicin Combined to Azacitidine in Int-2 or High Risk Myelodysplastic Syndromes

High Grade Myelodysplastic Syndrome Lesions

France, Tunisia
Groupe Hospitalier Pitie-Salpetriere

Completed

Pharmacokinetic Study of Antibiotics in Patients Assisted by Extracorporeal Membrane Oxygenation (PHARMECMO) (PHARMECMO)

Sepsis | Extracorporeal Membrane Oxygenation | Intensive Care Unit | Antibiotics
Groupe Hospitalier Pitie-Salpetriere

Completed

Evaluation of Readability of Consent Forms on the Understanding of the Information Received by Volunteers

Language | Outcome Assessments (Health Care) | Comprehension
Groupe Hospitalier Pitie-Salpetriere

Unknown

Evaluation of the Discontinuation of Maintenance Corticosteroid Treatment in Quiescent Systemic Lupus (CORTICOLUP)

Systemic Lupus Erythematosus

France
Groupe Hospitalier Pitie-Salpetriere

Completed

Atorvastatin After Aneurysmal Subarachnoid Hemorrhage

SAH
Groupe Francophone des Myelodysplasies

Unknown

Darbepoetin Alpha in Myelodysplastic Syndromes (MDS)

Myelodysplastic Syndromes

France
Groupe Francophone des Myelodysplasies

Completed

Thalidomide at Low Dose for the Treatment of Patient With Myelodysplastic Syndromes - THAL-SMD-200

Myelodysplastic Syndromes

France
Groupe Francais d'Epidemiologie Psychiatrique

Unknown

Evaluation of the Effects of Post-Immediate Psychotherapeutic Interventions in Secondary Prevention of Psychotraumatic Disorders (IPPI A)

PTSD Post Traumatic Syndrome Disorder

France
Groupe Francophone des Myelodysplasies

Unknown

Bortezomib and Low Dose Cytarabine in the Treatment of High-Risk Myelodysplastic Syndromes

Myelodysplastic Syndromes

France
Groupe Hospitalier Nord-Essonne

Recruiting

Reduction of Breast Hypertrophy by Means of Coelioscopique Surgery (R-HTM-R)

Breast Reduction

France
Groupe Hospitalier Pitie-Salpetriere

Recruiting

Pharmacokinetics Study Of Rivaroxaban and Apixaban in Cancer Patients (EPRAPAC)

Anticoagulants and Thrombotic Disorders

France
Groupe Hospitalier du Havre

Recruiting

French Validation of the CAPTURE Case Finding Tool for Obstructive Respiratory Disease

Lung Diseases | Lung Diseases, Obstructive | Obstructive Pulmonary Disease

France
Groupe Hospitalier Pitie-Salpetriere

Recruiting

Reporting, Evaluating, Preventing and Treating the Cardiotoxicity Induced by Anticancer Drugs During a Specific Cardio-oncology Consult and Follow up in Routine Care (NEOCARDIO)

Metabolic Disorder | Cardiac Insufficiency | Oncologic Complications | Cardiac Complication | Cardiovascular Complication | Cardiovascular Insufficiency | Cardiac Disorder | Vascular Disorder

France
Sudimplant SAS - Groupe TBR

Active, not recruiting

In Vivo Clinical Investigation of the Safety and Performance of Dental Implants TBR® Bone Level

Edentulous

France
Sudimplant SAS - Groupe TBR

Active, not recruiting

In Vivo Clinical Investigation of the Safety and Performance of Dental Implants TBR® Tissue Level Z1 (Z1)

Edentulous Mouth

France
Groupe Francophone des Myelodysplasies

Active, not recruiting

BST-236 as a Single Agent in Adults With Relapsed or Refractory AML or HR-MDS

Acute Myeloid Leukemia | Myelodysplastic Syndromes

France
Groupe Francophone des Myelodysplasies

Active, not recruiting

IDH1 (AG 120) Inhibitor in Patients With IDH1 Mutated Myelodysplastic Syndrome

Acute Myeloid Leukemia | Myelodysplastic Syndromes

France, Italy
Groupe Hospitalier Pitie-Salpetriere

Completed

Acute Kidney Injury in Adult Patients Supported by VA-ECMO (AKI-ECMO)

Acute Kidney Injury | Cardiogenic Shock

France
Groupe Hospitalier Pitie-Salpetriere

Completed

Monitoring the Antiphospholipid Syndrome:TOXicity of Drugs (APSTOX) (APSTOX)

Antiphospholipid Syndrome | Adverse Drug Event | Drug Toxicity | Immune Disease

France
Groupe Hospitalier Pitie-Salpetriere

Completed

Evaluation of Reporting of Cardio-vascular Adverse Events With Antineoplastic and Immunomodulating Agents (EROCA) (EROCA)

Cancer | Cardiac Disease

France

Clinical Trials Sponsored by Groupe Fontalvie

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovakia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations